Literature DB >> 19344936

Postoperative mortality after primary cytoreductive surgery for advanced stage epithelial ovarian cancer: a systematic review.

Cornelis G Gerestein1, Ronald A M Damhuis, Curt W Burger, Geertruida S Kooi.   

Abstract

OBJECTIVE: Accurate estimation of the risk of postoperative mortality (POM) is essential for the decision whether or not to perform cytoreductive surgery in a patient with advanced stage ovarian cancer. To ascertain modern reference figures, a systematic review of studies reporting POM after primary cytoreductive surgery for advanced stage epithelial ovarian cancer (EOC) was performed.
MATERIALS AND METHODS: A Medline search was performed to retrieve papers on primary cytoreductive surgery for advanced stage EOC. Twenty-three papers met the inclusion criteria and were reviewed.
RESULTS: According to population-based studies, POM after primary cytoreductive surgery for EOC is 3.7% on average. Single centre studies report an average rate of 2.5%. The overall mean POM is 2.8%. POM is more frequent for elderly women and after extensive procedures. Accurate information on age-specific and procedure-specific rates could not be obtained.
CONCLUSION: POM rates after surgery for EOC are satisfactorily low. There is a clear need for reliable reference figures for mortality after debulking surgery in the elderly.

Entities:  

Mesh:

Year:  2009        PMID: 19344936     DOI: 10.1016/j.ygyno.2009.03.011

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  19 in total

1.  Risk stratification and outcomes of women undergoing surgery for ovarian cancer.

Authors:  Sonali Patankar; William M Burke; June Y Hou; Ana I Tergas; Yongmei Huang; Cande V Ananth; Alfred I Neugut; Dawn L Hershman; Jason D Wright
Journal:  Gynecol Oncol       Date:  2015-05-11       Impact factor: 5.482

2.  Complications and Survivorship Trends After Primary Debulking Surgery for Ovarian Cancer.

Authors:  Zhaomin Xu; Adan Z Becerra; Carla F Justiniano; Christopher T Aquina; Fergal J Fleming; Francis P Boscoe; Maria J Schymura; Abdulrahman K Sinno; Jessica Chaoul; Gary R Morrow; Lori Minasian; Sarah M Temkin
Journal:  J Surg Res       Date:  2019-09-24       Impact factor: 2.192

3.  Laparoscopic Surgical Algorithm to Triage the Timing of Tumor Reductive Surgery in Advanced Ovarian Cancer.

Authors:  Nicole D Fleming; Alpa M Nick; Robert L Coleman; Shannon N Westin; Pedro T Ramirez; Pamela T Soliman; Bryan Fellman; Larissa A Meyer; Kathleen M Schmeler; Karen H Lu; Anil K Sood
Journal:  Obstet Gynecol       Date:  2018-09       Impact factor: 7.661

4.  Development and validation of a risk-calculator for adverse perioperative outcomes for women with ovarian cancer.

Authors:  Stephanie Cham; Ling Chen; Caryn M St Clair; June Y Hou; Ana I Tergas; Alexander Melamed; Cande V Ananth; Alfred I Neugut; Dawn L Hershman; Jason D Wright
Journal:  Am J Obstet Gynecol       Date:  2019-02-13       Impact factor: 8.661

5.  Comparative effectiveness research in gynecologic oncology.

Authors:  Sonali Patankar; Ana I Tergas; Jason D Wright
Journal:  Cancer Treat Res       Date:  2015

6.  Peri-operative blood management of Jehovah's Witnesses undergoing cytoreductive surgery for advanced ovarian cancer.

Authors:  Innocenza Palaia; Giuseppe Caruso; Violante Di Donato; Giorgia Perniola; Giancarlo Ferrazza; Enrico Panzini; Maria Scudo; Anna Di Pinto; Ludovico Muzii; Pierluigi Benedetti Panici
Journal:  Blood Transfus       Date:  2021-02-25       Impact factor: 3.443

Review 7.  Surgery in Advanced Ovary Cancer: Primary versus Interval Cytoreduction.

Authors:  Mackenzie Cummings; Olivia Nicolais; Mark Shahin
Journal:  Diagnostics (Basel)       Date:  2022-04-14

8.  Hyperthermic intraperitoneal chemotherapy for ovarian cancer: is there a role?

Authors:  C William Helm
Journal:  J Gynecol Oncol       Date:  2015-01       Impact factor: 4.401

9.  Diagnosis and management of peritoneal metastases from ovarian cancer.

Authors:  Evgenia Halkia; John Spiliotis; Paul Sugarbaker
Journal:  Gastroenterol Res Pract       Date:  2012-07-19       Impact factor: 2.260

10.  Multi-center evaluation of post-operative morbidity and mortality after optimal cytoreductive surgery for advanced ovarian cancer.

Authors:  Arash Rafii; Eberhard Stoeckle; Mehdi Jean-Laurent; Gwenael Ferron; Philippe Morice; Gilles Houvenaeghel; Fabrice Lecuru; Eric Leblanc; Denis Querleu
Journal:  PLoS One       Date:  2012-07-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.